Evidence map›Paper›PMID 29997616›Full record

ArticleFrontiers in immunology2018

Probiotic

Astghik Pepoyan, Marine Balayan, Anahit Manvelyan, Lilit Galstyan, Sofi Pepoyan, Susanna Petrosyan, Vardan Tsaturyan, Shigeru Kamiya, Tamas Torok, Michael Chikindas

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 33 citations in OpenAlex.

  1. Placebo-resistant gut bacteria:Frontiers in cellular and infection microbiology · 2024
    Trial
  2. Trial
  3. Review
  4. Highlights on the Contribution of Gut Microbiota to Immune-Mediated Diseases in Childhood.Mediterranean journal of hematology and infectious diseases · 2026
    Review
  5. Article
  6. GutWomen's health reports (New Rochelle, N.Y.) · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Anticandidal Activities byFrontiers in oral health · 2021
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Astghik PepoyanDepartment of Food Safety and Biotechnology, Armenian National Agrarian University, Yerevan, Armenia.
Marine BalayanInternational Association for Human and Animals Health Improvement, Yerevan, Armenia.
Anahit ManvelyanDepartment of Food Safety and Biotechnology, Armenian National Agrarian University, Yerevan, Armenia.
Lilit GalstyanYerevan State Medical University, Yerevan, Armenia.
Sofi PepoyanInternational Association for Human and Animals Health Improvement, Yerevan, Armenia.
Susanna PetrosyanArmenian National Agrarian University, Yerevan, Armenia.
Vardan TsaturyanYerevan State Medical University, Yerevan, Armenia.
Shigeru KamiyaKyorin University School of Medicine, Tokyo, Japan.
Tamas TorokLawrence Berkeley National Laboratory, Berkeley, CA, United States.
Michael ChikindasHealth Promoting Naturals Laboratory, School of Environmental and Biological Sciences, Rutgers State University, New Brunswick, NJ, United States.
Armenian National Agrarian University · AMYerevan State Medical University · AMKyorin University · JPLawrence Berkeley National Laboratory · USRutgers, The State University of New Jersey · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intestinal microorganisms play a crucial role in health and disease. The disruption of host-microbiota homeostasis has been reported to occur not only during disease development but also as a result of medication. Familial Mediterranean fever (FMF) is an inflammatory genetic disease characterized by elevated systemic reactivity against the commensal gut microbiota and high levels of

Indexed as

Candida albicansEnterobacteriaceaeEnteroccocus faecalisfamilial Mediterranean fevergendergut microbiotaLactobacillus acidophilus INMIA 9602 Er 317/402M694V/V726A mutations

Identifiers

PMID29997616
PMCPMC6028570
OpenAlexW2807716845

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.